Skip to main content

QUEST DIAGNOSTICS INC insider trading

DGXNYSE
$233.33+2.24 (+0.97%)as of Oct 2, 2026

“Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.” — Peter Lynch

Insider Trading vs Stock Price

Insider Trading vs Stock Price data

Showing the 1Y range: Oct 2, 2025 to Oct 2, 2026. Price (+28.9%). 0 insider transactions plotted in this window as 0 markers; nearby trades of the same kind are grouped.

Transactions plotted on the price chart
DateCategoryPersonRoleActionAmountChange in holding
Open market purchase
Open market sell
Marker size reflects transaction size.

Net dollar flow · Buy / Sell balance

Premium
Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Unlock quarterly net flow

Key players

  • JEJ. E. DavisCEO and President0.1109%of company
  • CTCatherine T. DohertyEVP, Regional Businesses0.0649%of company
  • MEMichael E. PrevoznikSVP & General Counsel0.0384%of company
  • MJMichael J. DeppeSVP, Corp. Controller & CAO0.0319%of company
  • SSSam SamadExecutive Vice President & CFO0.0303%of company
  • TMTimothy M. RingDirector0.0282%of company
  • GMGary M. PfeifferDirector0.0281%of company
  • TLTimothy L. MainDirector0.0249%of company
  • VBVicky B. GreggDirector0.0167%of company
  • KKKarthik KuppusamySVP, Clinical Solutions0.0141%of company

AI Activity Analysis

Premium
Coming soonAI reads of insider activity will appear here for Premium accounts.

Insider activity

Fromto
CompanyInsider / roleActionΔOwnAvg priceAmount
DGXJ. E. DavisCEO and PresidentOpen market sell$2.43M-7.6%$242.72$2.43MSep 1, 2026Sep 3, 2026
DGXMark E. DelaneySVP & Chief Commercial OfficerOpen market sell$376K-13.4%$235.18$376KJul 28, 2026Jul 29, 2026
DGXJ. E. DavisCEO and PresidentOpen market sell$1.94M-7.0%$194.14$1.94MJun 1, 2026Jun 2, 2026
DGXCatherine T. DohertyEVP, Regional BusinessesOpen market sell$1.15M-7.2%$206.21$1.15MMar 5, 2026Mar 6, 2026
DGXMichael E. PrevoznikSVP & General CounselOpen market sell$800K-8.2%$206.21$800KMar 5, 2026Mar 6, 2026
DGXPatrick PlewmanSVP for Diagnostic ServicesOpen market sell$589K-15.8%$206.21$589KMar 5, 2026Mar 6, 2026
DGXKarthik KuppusamySVP, Clinical SolutionsOpen market sell$538K-14.5%$204.86$538KMar 4, 2026Mar 6, 2026
DGXCatherine T. DohertyEVP, Regional BusinessesOpen market sell$131K-0.9%$207.73$131KMar 3, 2026Mar 4, 2026
DGXMichael E. PrevoznikSVP & General CounselOpen market sell$109K-1.2%$207.73$109KMar 3, 2026Mar 4, 2026
DGXPatrick PlewmanSVP for Diagnostic ServicesOpen market sell$85.2K-2.6%$207.73$85.2KMar 3, 2026Mar 4, 2026
DGXJ. E. DavisCEO and PresidentOpen market sell$2.13M-7.9%$212.52$2.13MMar 2, 2026Mar 4, 2026
DGXCatherine T. DohertyEVP, Regional BusinessesOpen market sell$294K-1.9%$204.83$294KFeb 19, 2026Feb 20, 2026
DGXPatrick PlewmanSVP for Diagnostic ServicesOpen market sell$196K-5.7%$204.83$196KFeb 19, 2026Feb 20, 2026
DGXMichael E. PrevoznikSVP & General CounselOpen market sell$228K-2.5%$204.83$228KFeb 19, 2026Feb 20, 2026
DGXVicky B. GreggDirectorOpen market sell$240K-6.8%$191.76$240KNov 25, 2025Nov 28, 2025
DGXGary M. PfeifferDirectorOpen market sell$270K-4.8%$182.40$270KOct 22, 2025Oct 24, 2025
End of history · 16 transactions
SpoorBase

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.